WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010117829) DIFFERENTIALLY EXPRESSED MICRORNAS AS BIOMARKERS FOR THE DIAGNOSIS AND TREATMENT OF SJÖGREN'S SYNDROME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/117829    International Application No.:    PCT/US2010/029307
Publication Date: 14.10.2010 International Filing Date: 31.03.2010
IPC:
C12Q 1/68 (2006.01), C12N 15/11 (2006.01), A61K 31/7105 (2006.01), A61K 48/00 (2006.01), A61P 37/00 (2006.01)
Applicants: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES [US/US]; National Institutes of Health Office of Technology Transfer 6011 Executive Blvd. Suite 325 Msc 7660 Bethesda, MD 20892-7660 (US) (For All Designated States Except US).
ALEVIZOS, Ilias [GR/US]; (US) (For US Only).
ILLEI, Gabor [HU/US]; (US) (For US Only)
Inventors: ALEVIZOS, Ilias; (US).
ILLEI, Gabor; (US)
Agent: CONNOLLY, Jodi, L.; Klarquist Sparkman, LLP One World Trade Center, Suite 1600 121 Sw Salmon Street Portland, OR 97204 (US)
Priority Data:
61/165,142 31.03.2009 US
Title (EN) DIFFERENTIALLY EXPRESSED MICRORNAS AS BIOMARKERS FOR THE DIAGNOSIS AND TREATMENT OF SJÖGREN'S SYNDROME
(FR) MICRO-ARN D'EXPRESSION DIFFÉRENTIELLE UTILISÉS COMME BIOMARQUEURS DU DIAGNOSTIC DU SYNDROME DE SJÖGREN ET TRAITEMENT ASSOCIÉ
Abstract: front page image
(EN)The identification of differentially expressed microRNAs in patients with Sjögren's syndrome is disclosed herein. Provided is a method of diagnosing a subject as having Sjögren's syndrome by measuring the level of at least one differentially expressed miR gene product identified herein. An alteration in the level of the at least one miR gene product in the biological sample of the subject relative to a control indicates the subject has Sjögren's syndrome. Also provided is a method of treating a patient with Sjögren' s syndrome by administering to the patient a therapeutically effective amount of an agent that inhibits expression of a miR gene product that is up-regulated in the patient with Sjögren's syndrome relative to a control, or by administering to the patient a therapeutically effective amount of an isolated miR gene product that is down-regulated in the patient with Sjögren's syndrome relative to a control A method of restoring salivary flow in a patient with Sjögren' s syndrome is also provided.
(FR)Cette invention concerne l'identification de micro-ARN d'expression différentielle chez les patients atteints du syndrome de Sjögren. L'invention concerne une méthode de diagnostic d'un sujet atteint du syndrome de Sjögren en mesurant le taux d'au moins un produit génétique micro-ARN d'expression différentielle identifié dans l'invention. Une modification du taux dudit produit génétique du micro-ARN dans l'échantillon biologique prélevé chez le sujet par rapport à un témoin est indicatrice du syndrome de Sjögren chez le sujet. L'invention concerne également une méthode de traitement d'un patient atteint du syndrome de Sjögren en administrant audit patient une quantité thérapeutiquement efficace d'un agent qui inhibe l'expression d'un produit génétique de micro-ARN régulé à la hausse chez le patient par rapport à un témoin, ou en administrant audit patient une quantité thérapeutiquement efficace d'un produit génétique micro-ARN isolé qui est régulé à la baisse chez le patient atteint du syndrome de Sjögren par rapport à un témoin. L'invention concerne également une méthode permettant de restaurer le flux salivaire chez le patient atteint du syndrome de Sjögren.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)